Medilot

Medilot

Created using Figma
MediLOT ICO adalah ekosistem EHR berbasis rantai ganda blok hierarki unik yang menggabungkan pembelajaran mesin dan fungsi analisis data di atas kontrol dan lapisan data dan membangun API pembelajaran mesin dengan aplikasi kompleks pada sistem yang dapat saya lakukan.

Dengan memiliki buku besar distribusi (Hyperledger ++) yang mencatat semua transaksi, seluruh data pasien jangka panjang dapat dicari kapan saja oleh petugas kesehatan yang berwenang untuk penggunaan klinis. Catatan kesehatan ini dapat diakses dengan persetujuan pasien di antara berbagai lembaga.
To be announced
Detail Token
Jantung
LOT
Mata Uang yang Diterima
ETH
Detail Perusahaan
Negara Terdaftar
Singapore
detil tambahan
Kategori
Peron, Kesehatan

Tentang Medilot

MediLOT adalah ekosistem EHR berbasis blockchain ganda dengan arsitektur berlapis unik yang menggabungkan pembelajaran mesin dan kemampuan analisis data di atas kontrol dan lapisan datanya, memungkinkan API pembelajaran mesin dengan aplikasi kompleks untuk dibangun di atas sistem. < / p>

Dengan memiliki buku besar yang didistribusikan (Hyperledger ++) yang mencatat semua transaksi, seluruh data pasien longitudinal dapat diambil kapan saja oleh praktisi kesehatan yang berwenang untuk penggunaan klinis. Catatan kesehatan ini kemudian dapat diakses, dengan izin dari pasien, di berbagai institusi. Sebagai contoh, seorang pasien yang mengunjungi rumah sakit yang belum pernah dirawat sebelumnya tidak akan diminta untuk mengulangi penyelidikan, karena dokter atau dokter yang telah diberikan hak akses dapat mengakses seluruh catatan kesehatannya melalui MediLOT. Selain itu, pilihan persetujuan yang berbeda, seperti yang melibatkan donasi organ, arahan medis dan penelitian lanjutan, juga dapat dicatat pada blockchain dan diakses secara universal. Secara khusus, pilihan persetujuan yang melibatkan penggunaan data untuk penelitian dapat ditangkap secara granular, memungkinkan para peneliti untuk segera melihat apakah pasien menyetujui data mereka untuk digunakan untuk penelitian, termasuk penggunaan bahan biologis mereka, serta apakah akan identifikasi diperbolehkan jika ada kebutuhan.

% name% Roadmap

  • Q1 2019

  • Lite Mainnet up in community clinic setting.
  • Q2 2019

  • Complete ForkBase Integration.
  • Q3 2019

  • Testnet up in hospital setting.
  • Q1 2020

  • Limited Mainnet with core functionality in one geographical cluster.
  • Baca lebih banyak
  • Q2 2020

  • GEMINI Trial.
  • Q4 2020

  • Mainnet online in Singapore.
  • Q2 2021

  • Asia Mainnet launch.

Medilot Tim

Diverifikasi 0%

Perhatian. Ada risiko bahwa anggota yang tidak diverifikasi sebenarnya bukan anggota tim

Ooi Beng Chin
Founder
tidak diverifikasi
Ngiam Kee Yuan
Founder
tidak diverifikasi
Marcus Tan
Founder
tidak diverifikasi
Zhang Meihui
Founder
tidak diverifikasi
Zhang Jiangwei
Founder
tidak diverifikasi
Zhang Dongxiang
tidak diverifikasi
Dinh Tien Tuan Anh
tidak diverifikasi
Andreea Costea
tidak diverifikasi
Dumitrel Loghin
tidak diverifikasi
Ruan Pingcheng
tidak diverifikasi

Penasihat

Diverifikasi 0%

Perhatian. Ada risiko bahwa anggota yang tidak diverifikasi sebenarnya bukan anggota tim

James Yip
tidak diverifikasi

5 ICO

$76 640 353

Shaun Djie
tidak diverifikasi
Phan Vee Leung
tidak diverifikasi

Medilot Berita terakhir

N/A
5.0 19
WEB2 Profil Penglihatan Aktivitas Potensi Produk Tim

% name% Ulasan

ICO Pantera
A+
Baca lebih banyak
Midgard Research

We believe that MediLOT is one of the exciting upcoming IEO and here are the reasons why:
First of all, the project is formulated and executed by a Singapore-based team with solid experience in medicine, tech and business development. The core members are from the blockchain and healthcare spheres:
- Co-founder Professor Beng Chin Ooi is 1 of the 2 Distinguished Professors and has spent over 30 years at the National University of Singapore's Department of Computer Science
- Co-founder Professor Meihui Zhang is a Professor at the Beijing Institute of Technology and a winner of prestigious China's Young Scholar Thousand Talents Program in 2018
- Co-founder Dr Marcus Tan is an Opthalmologist (Eye Specialist) and a Clinical Lecturer at the National University of Singapore
- CEO Koon Swee Lim has 25 years of senior management experience in healthcare industry, biomedical technology commercialisation and investments
The research done by MediLOT's team of professors has been cited in many reputable publications. 
Backed by equity investor SG Innovate, the Singapore Government Venture Capital Fund, MediLot has a monopoly in Singapore, having already partnered with National University Hospital (the largest medical research institution in Singapore). More contracts with other Singapore hospitals will be announced. The team has also secured a foothold in the fast-growing China healthcare market.  
Secondly, we like the idea of the project because it has a real use-case with seamless adoption of blockchain in our daily life. In summary, MediLOT is a dual blockchain-based Electronic Health Records platform that allows individual patients to grant healthcare providers, research institutions and pharmaceuticals access to their encrypted medical data by indicating the storage location. This is a highly secure solution which adheres to GDPR and other stringent data privacy regulations. Patients will be incentivized and empowered to permit the usage of their data to facilitate research, such as the research to create new drugs and treatments for cancers.
Thirdly, the token metrics is reasonable while the tokenomics is deflationary. IEO hardcap is $1,500,000 (for 8.5% of total token supply) while the initial circulating supply is $2,168,366. LOT Tokens retained by the MediLOT Platform will be burnt.  
Last but not least, Ricky Ng, the founder of Bitsdaq, is one of the advisors, so we will keep an eye on it. Probably it will be an IEO on Bitsdaq Exchange

Baca lebih banyak
Crypto Calibur
82

Medilot has flown under the radar for many of us not focused on developments in Asia but the project has a number of strong points. These include the fact that Medilot is operating in a lucrative sector and has a very much needed use case and is attempting to disrupt an industry that has been using outdated methods for quite some time. On top of this, the project has already developed an MVP and various aspects of the code are available to be verified. Medilot also has a strong core team with partnerships/collaborations with the National University of Singapore, the National University Health System, Singapore, and Chinese hospitals such as the Shandong Province Hospital, the Zhejiang Chinese Medical University Affiliated Jiangnan Hospital, and the Shenzhen Kingcome Hospital.
They have also been backed by SGInnovate, Signum Capital, and two other renowned investors who wish to remain private. which shows they are developing something significant, however, due to the scope of the project Medilot could prove to be a slow burner. There is a long wait until the mainnet with a launch set for Singapore in Q4 2020, and the Asia launch is in Q3 2021. This will leave the LOT token open to pure speculation for quite a while and could even allow the market to grow cold on the project. In addition, in the long term LOT tokens rely on adoption to maintain value and there’s no guarantee this will happen anytime soon. Furthermore, the team do state that in the preliminary stage, organisations who do not wish to stake LOT can deposit fiat which will be treated as a security deposit. This won’t help the token price when the project is getting off the ground, however, the team aim to retain 30% of all LOT Tokens via the platform’s fee structure regarding data sharing. Also LOT tokens held by the Platform will be held to insure against Black Swan events, and may also be burnt by the management as well as locked up by institutions and organisations that choose to stake tokens. The low token sale ratio also increases the importance of the team’s token management; however, with the team getting ready to conduct an IEO, there should be enough positive price action to attract anyone looking for short term returns. Anyone looking to follow the project in the long term should keep an eye on developments and adoption community growth over the next year as the project nears its first mainnet launch.

Baca lebih banyak
dbcrypto
B
Baca lebih banyak
G.Crypto
Baca lebih banyak
Lihat semua (% hitung%)
  • Karena mungkin ada perbedaan waktu dalam pembaruan informasi, informasi akurat tentang setiap proyek ICO harus diverifikasi melalui situs resminya atau saluran komunikasi lainnya.
  • Informasi ini bukan saran atau saran tentang berinvestasi dalam pendanaan ICO. Silakan teliti sendiri informasi yang relevan dan putuskan partisipasi ICO.
  • Jika Anda merasa ada masalah atau masalah yang harus diperbaiki pada konten ini, atau jika Anda ingin mengirimkan proyek ICO Anda sendiri untuk dicantumkan, Harap email kami.
Silahkan baca disclaimer dan risk warning. Tampilkan disclaimer dan risk warning.